Biktarvy, formally known as bictegravir, includes a powerful single-tablet regimen for controlling HIV infection. This medication combines three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the HIV's ability to replicate within the body, considerably decreasing the viral load. For many individua